What is the meningococcal B vaccine?
The meningococcal B vaccine (MenB) protects against a fifth type of meningococcal bacterium (called type B). It is fairly new and not yet recommended as a routine vaccination for healthy people. But some kids and teens who are at increased risk for meningococcal disease should get it starting from age 10.
When do you give meningococcal B vaccine?
Administer MenB vaccines at 16 through 18 years of age to maximize protection when adolescents are at highest risk. CDC recommends vaccine providers who choose to administer the MenB vaccine series give it in later adolescence. The preferred age at which to administer MenB vaccine is between 16 to 18 years.
What is the bexsero vaccine for?
BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals aged 10 through 25 years.
Is the meningococcal B vaccine safe?
Available data suggest that MenB vaccines are safe. More than half of the people who get a MenB vaccine have mild problems following vaccination: Soreness, redness, or swelling where the shot was given. Feeling tired (fatigue)
How many meningitis B shots are required?
Healthy adolescents who are not at increased risk for meningococcal B disease should receive 2 doses of Trumenba (MenB-FHbp) administered at 0 and 6 months. If the second dose is given at an interval of less than 6 months, a third dose should be given at least 4 months after the 2nd dose.
How many meningococcal B vaccines are required for babies?
From 1 July 2020, the meningococcal B vaccine will be given at the same time as other routine baby vaccinations at 2, 4 and 12 months. An extra dose at 6 months is required for infants who have certain risk conditions. It is important that all doses are given to ensure your child is protected.
Who needs meningococcal vaccine?
Who should get the meningococcal vaccines? All children ages 11 through 12 years should receive meningococcal vaccine (MenACWY) followed by a booster dose at age 16 years. Vaccination is also recommended for all adolescents ages 13 through 18 years who did not receive a dose at age 11-12 years.
Is bexsero safe for babies?
Bexsero is the only MenB vaccine that can be used in infants and children aged <10 years. The number of doses required depends on the age of the child when they start the vaccine course.
When should bexsero be given?
The primary infant series consists of three doses, given at 2, 4 and 6 months of age, followed by a fourth dose (booster). The primary series can also be given at 2, 3 and 4 months of age, but the immune response to the NHBA antigen is lower.
Does meningococcal vaccine have side effects?
More than half of the people who get a MenB vaccine have mild problems following vaccination: Soreness, redness, or swelling where the shot was given. Feeling tired (fatigue) Headache.